Anebulo Pharmaceuticals, Inc.
ANEB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,158 | -$2,145 | -$1,676 | -$2,463 |
| Dep. & Amort. | $0 | $0 | $245 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $238 | $340 | $255 | $0 |
| Change in WC | $630 | $135 | -$426 | $433 |
| Other Non-Cash | $17 | $17 | $0 | $624 |
| Operating Cash Flow | -$1,273 | -$1,652 | -$1,602 | -$1,406 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | -$117 | $15,000 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $0 | -$117 | $15,000 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1,273 | -$1,652 | -$1,719 | $13,594 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $11,628 | $13,280 | $14,998 | $1,404 |
| End Cash | $10,355 | $11,628 | $13,280 | $14,998 |
| Free Cash Flow | -$1,273 | -$1,652 | -$1,602 | -$1,406 |